AXTI AXT INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 1051627 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY89.1%
TTM net income YoY239.0%
TTM EPS YoY192.5%
Revenue 3-yr CAGR27.7%
Net income 3-yr CAGR—
Margins
Gross margin44.0%
Operating margin19.6%
Net margin18.5%
FCF margin46.5%
EBITDA margin25.3%
Returns
ROE5.8%
ROA4.1%
ROIC (approx.)8.3%
Asset turnover0.22x
Leverage & solvency
Liabilities / assets19.3%
Debt / equity0.10x
Current ratio3.80x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.32x
Accruals ratio-9.5%
Payout ratio—
Capex / revenue15.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $73.41M | $47.59M | $26.92M | $23.04M | $27.95M | $17.97M | $19.36M | $25.11M |
| Cost of revenue | $32.31M | $26.22M | $18.95M | $18.21M | $21.73M | $16.54M | $20.60M | $20.70M |
| Gross profit | $41.09M | $21.37M | $7.98M | $4.83M | $6.22M | $1.43M | -$1.24M | $4.41M |
| R&D expense | $3.94M | $3.65M | $3.01M | $2.39M | $1.01M | $2.52M | $3.12M | $4.13M |
| SG&A expense | $8.72M | $7.29M | $6.55M | $6.27M | $6.33M | $5.65M | $5.92M | $6.44M |
| Operating income | $28.43M | $10.42M | -$1.58M | -$3.83M | -$1.12M | -$6.75M | -$10.28M | -$6.17M |
| Interest expense | — | — | — | $391,000 | $395,000 | $202,000 | — | $318,000 |
| Pretax income | $34.32M | $15.13M | -$1.05M | -$3.34M | -$1.17M | -$7.09M | -$9.94M | -$5.54M |
| Income tax | $4.57M | $2.10M | $430,000 | $501,000 | $504,000 | $579,000 | $74,000 | $113,000 |
| Net income | $25.72M | $11.13M | -$1.62M | -$3.55M | -$1.91M | -$7.01M | -$8.80M | -$5.09M |
| EBITDA | $31.04M | $12.93M | $850,000 | -$1.51M | $1.18M | -$4.49M | -$8.05M | -$3.92M |
| EPS (basic) | 0.40 | 0.18 | -0.03 | — | -0.04 | -0.16 | -0.20 | — |
| EPS (diluted) | 0.39 | 0.17 | -0.03 | — | -0.04 | -0.16 | -0.20 | — |
| Weighted avg. shares (diluted) | 65.86M | 63.47M | 53.32M | — | 43.84M | 43.71M | 43.55M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $485.47M | $412.17M | $41.77M | $120.27M | $23.11M | $27.01M | $31.58M | $22.83M |
| Short-term investments | $27.27M | $5.03M | $65.38M | $0 | — | — | — | — |
| Receivables | $39.69M | $36.67M | $32.02M | $26.85M | $33.84M | $22.79M | $22.86M | $25.64M |
| Inventory | $103.66M | $96.32M | $90.17M | $81.65M | $77.66M | $80.06M | $80.41M | $85.08M |
| Current assets | $724.62M | $598.80M | $253.78M | $246.56M | $149.75M | $144.96M | $149.53M | $158.27M |
| PP&E, net | $194.37M | $174.92M | $164.62M | $161.86M | $159.28M | $159.71M | $159.03M | $159.72M |
| Total assets | $1.22B | $1.10B | $444.60M | $433.75M | $334.03M | $329.00M | $333.48M | $339.31M |
| Current liabilities | $190.91M | $125.66M | $97.88M | $90.54M | $84.90M | $79.54M | $75.26M | $74.18M |
| Short-term debt | $72.46M | $84.23M | $68.87M | $62.80M | $61.55M | $55.93M | $1.70M | $47.26M |
| Long-term debt | $15.50M | — | — | — | — | — | — | — |
| Total debt | $87.96M | — | — | — | — | — | — | — |
| Total liabilities | $235.06M | $145.34M | $107.63M | $99.12M | $93.58M | $88.37M | $87.31M | $84.41M |
| Shareholders' equity | $913.35M | $887.27M | $274.87M | $273.29M | $179.15M | $179.71M | $185.04M | $192.77M |
| Net debt | -$397.51M | — | — | — | — | — | — | — |
| Shares outstanding | 65.57M | 65.57M | 55.58M | 55.24M | 46.22M | 46.08M | 45.60M | 45.36M |
| Cash flow statement | ||||||||
| Operating cash flow | $101.67M | $10.78M | -$11.68M | $4.29M | -$9.15M | -$4.58M | -$3.35M | $1.27M |
| Capital expenditure | $13.98M | $7.23M | $1.37M | $3.03M | $2.17M | $279,000 | $510,000 | $167,000 |
| Free cash flow | $87.69M | $3.56M | -$13.06M | $1.26M | -$11.33M | -$4.86M | -$3.86M | $1.10M |
| Investing cash flow | -$11.82M | -$246.90M | -$67.26M | -$3.03M | -$2.17M | -$840,000 | -$786,000 | -$441,000 |
| Financing cash flow | -$12.79M | $621.36M | $7.99M | $95.34M | $5.19M | -$321,000 | $6.88M | -$5.04M |
| Depreciation & amortization | $2.61M | $2.51M | $2.44M | $2.32M | $2.31M | $2.26M | $2.22M | $2.24M |
| Stock-based compensation | $1.07M | $762,000 | $1.03M | $1.27M | $738,000 | $633,000 | $646,000 | $753,000 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.